Detalles de la búsqueda
1.
Discontinuation of psychotropic medication: a synthesis of evidence across medication classes.
Mol Psychiatry;
2024 Mar 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-38503923
2.
The Relationship of Early Sleep Improvement With Response to Pharmacotherapy in Unipolar Psychotic Depression.
J Clin Psychopharmacol;
43(6): 486-492, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37930199
3.
Acute Neuropsychiatric Symptoms During COVID-19: Results From Two Independent Cohort Studies.
J Nerv Ment Dis;
211(10): 779-783, 2023 10 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37557068
4.
Effect of Past Pharmacotherapy for Attention-Deficit/Hyperactivity Disorder on Substance Use Disorder.
Eur Addict Res;
29(1): 9-18, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-36349763
5.
Patients' Perspectives on the Development of Prescription Opioid Use Disorder in Patients with Chronic Non-Cancer Pain.
Eur Addict Res;
29(2): 141-149, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37062280
6.
Effectiveness of a group intervention to reduce sexual transmission risk behavior among MSM living with HIV: a non-randomized controlled pilot study.
AIDS Care;
34(4): 515-526, 2022 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-34851810
7.
The clinical course of comorbid substance use disorder and attention deficit/hyperactivity disorder: protocol and clinical characteristics of the INCAS study.
BMC Psychiatry;
22(1): 625, 2022 09 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-36151539
8.
Effects of substance misuse on inhibitory control in patients with attention-deficit/hyperactivity disorder.
Addict Biol;
27(1): e13063, 2022 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34101312
9.
Effects of family history of substance use disorder on reward processing in adolescents with and without attention-deficit/hyperactivity disorder.
Addict Biol;
27(2): e13137, 2022 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-35229951
10.
Cognitive Functioning in Long-Term Benzodiazepine Users.
Eur Addict Res;
28(5): 377-381, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36041417
11.
Barriers and Facilitators to Seek Help for Substance Use Disorder among Dutch Physicians: A Qualitative Study.
Eur Addict Res;
28(1): 23-32, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-34192705
12.
Monitoring Opioids in Europe: The Need for Shared Definitions and Measuring Drivers of Opioid Use and Related Harms.
Eur Addict Res;
28(3): 231-240, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35196659
13.
Cognitive Impairments in Patients with GHB Use Disorder Predict Relapse in GHB Use.
Eur Addict Res;
28(5): 350-357, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35853435
14.
Improving medical students' attitude toward patients with substance use problems through addiction medicine education.
Subst Abus;
43(1): 47-55, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-32105582
15.
Substance use, Unlike Dolutegravir, is Associated with Mood Symptoms in People Living with HIV.
AIDS Behav;
25(12): 4094-4101, 2021 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-33903997
16.
Youth in transition: Study protocol of a prospective cohort study into the long-term course of addiction, mental health problems and social functioning in youth entering addiction treatment.
BMC Psychiatry;
21(1): 605, 2021 12 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-34863131
17.
Associations between the CADM2 gene, substance use, risky sexual behavior, and self-control: A phenome-wide association study.
Addict Biol;
26(6): e13015, 2021 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-33604983
18.
Successful treatment of severe, treatment resistant GHB withdrawal through thiopental-coma.
Subst Abus;
42(1): 33-38, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-33044905
19.
The relationship between depressive symptoms, general psychopathology, and well-being in patients with major depressive disorder.
J Clin Psychol;
77(6): 1472-1486, 2021 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-33188711
20.
[International Consensus Statement for the Screening, Diagnosis, and Treatment of Adolescents with Concurrent Attention-Deficit/Hyperactivity Disorder and Substance Use Disorder]. / Internationale Konsenserklärung zu Screening, Diagnostik und Behandlung von Jugendlichen und Heranwachsenden mit Aufmerksamkeitsdefizit-/Hyperaktivitätsstörung und gleichzeitigen Störungen durch Substanzgebrauch.
Z Kinder Jugendpsychiatr Psychother;
50(1): 54-67, 2021 Jan.
Artículo
en Alemán
| MEDLINE | ID: mdl-34397296